Friedmund Bachmann

Friedmund Bachmann is Vice President CMC & Project Lead at OncoOne, where he leads CMC strategy and cross-functional development of the proprietary PreTarg-it® platform toward clinical translation. He brings more than 25 years of pharmaceutical and biotechnology experience spanning preclinical development, late-stage development, regulatory approval, commercialization, and lifecycle management. During his career, he has steered complex late-stage programs through major development challenges, positioning them for continued progression across the product lifecycle, including BLA approval and commercialization. His expertise spans radiopharmaceuticals and diverse biologic modalities across oncology, hematology, and inflammatory diseases. Friedmund combines scientific depth, strategic leadership, and operational execution.